Reply to Dr Yucel's Comments on the Article “Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia”

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia

(2023) Myung A. Lee et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia

(2021) T. Scott Stroup et al.   JAMA Psychiatry

Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

(2021) Elias Wagner et al.   Translational Psychiatry

The side effect profile of Clozapine in real world data of three large mental health hospitals

(2020) Ehtesham Iqbal et al.   PLoS One

Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode

(2019) Jolanta Zanelli et al.   AMERICAN JOURNAL OF PSYCHIATRY

Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders

(2019) Anne-Kathrin J. Fett et al.   JAMA Psychiatry

Change in Cognitive Performance From Midlife Into Old Age: Findings from the Midlife in the United States (MIDUS) Study

(2018) Matthew L. Hughes et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

(2016) Dan Siskind et al.   BRITISH JOURNAL OF PSYCHIATRY

Age-Associated Differences in Cognitive Performance in Older Patients With Schizophrenia: A Comparison With Healthy Older Adults

(2011) David A. Loewenstein et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY